Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB01201_DB05294_nanopub.RAaegwPpNYRbxj_fi0m6D-Vwhurk2xWNyue8Ymrc-5vMY#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB01201_DB05294 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB01201_DB05294 label "DDI between Rifapentine and Vandetanib - Decreases levels of vandetanib by affecting CYP3A4 metabolism. Contraindicated. [drugbank_resource:DB01201_DB05294]" assertion.
- drugbank_resource:DB01201_DB05294 identifier "drugbank_resource:DB01201_DB05294" assertion.
- drugbank_resource:DB01201_DB05294 title "DDI between Rifapentine and Vandetanib - Decreases levels of vandetanib by affecting CYP3A4 metabolism. Contraindicated." assertion.
- drugbank:DB05294 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01201_DB05294 assertion.
- drugbank:DB01201 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB01201_DB05294 assertion.